Abstract:Abstract Purpose of Review The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has affected lives of billions of individuals, globally. There is an urgent need to develop interventions including vaccines to control the ongoing pandemic. Recent Findings Development of tools for fast-tracked testing including small and large animal models for vaccine efficacy analysis, assays for immunogenicity assessment, critical reagents, international biological standards, and data sharing allowed accelerated development of vaccines. More than 300 vaccines are under development and 9 of them are approved for emergency use in various countries, with impressive efficacy ranging from 50 to 95%. Recently, several new SARS-CoV-2 variants have emerged and are circulating globally, and preliminary findings imply that some of them may escape immune responses against previous variants and diminish efficacy of current vaccines. Most of these variants acquired new mutations in their surface protein (Spike) which is the antigen in most of the approved/under development vaccines. Summary In this review, we summarize novel and traditional approaches for COVID-19 vaccine development including inactivated, attenuated, nucleic acid, vector and protein based. Critical assessment of humoral and cell-mediated immune responses induced by vaccines has shown comparative immunogenicity profiles of various vaccines in clinical phases. Recent reports confirmed that some currently available vaccines provide partial to complete protection against emerging SARS-CoV-2 variants. If more mutated variants emerge, current vaccines might need to be updated accordingly either by developing vaccines matching the circulating strain or designing multivalent vaccines to extend the breadth.

A systematic review of SARS-CoV-2 vaccine candidates

Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19)

The way of SARS-CoV-2 vaccine development: success and challenges

SARS-CoV-2: vaccines in the pandemic era

SARS-CoV-2: An Analysis of the Vaccine Candidates Tested in Combatting and Eliminating the COVID-19 Virus

Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects

Recent Advances in Vaccine Development of Severe Acute Respiratory Syndrome Coronavirus 2

COVID-19: An Overview of SARS-CoV-2 Variants—The Current Vaccines and Drug Development

SARS-CoV-2 vaccine candidates in rapid development

Coronavirus (SARS-CoV-2): a systematic review for potential vaccines

COVID-19: Coronavirus Vaccine Development Updates

Status Report on COVID-19 Vaccines Development

Safety, Tolerability, and Immunogenicity of COVID-19 Vaccines: A Systematic Review and Meta-Analysis

Coronavirus vaccine development: from SARS and MERS to COVID-19

The Variation of SARS-CoV-2 and Advanced Research on Current Vaccines

An Overview of SARS-CoV-2 Etiopathogenesis and Recent Developments in COVID-19 Vaccines

SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates

Research Progress on a SARS-CoV-2 Vaccine in China

Progress in SARS-CoV-2, Diagnostic and Clinical Treatment of COVID-19

Genomic variation, origin tracing, and vaccine development of SARS-CoV-2: A systematic review

Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection